These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8366471)

  • 21. Kinetics of platelet 5-hydroxytryptamine uptake in headache patients.
    Hannah P; Jarman J; Glover V; Sandler M; Davies PT; Clifford Rose F
    Cephalalgia; 1991 Jul; 11(3):141-5. PubMed ID: 1889070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The platelet and the neuron: two cells in focus in migraine.
    Malmgren R; Hasselmark L
    Cephalalgia; 1988 Mar; 8(1):7-24. PubMed ID: 3282671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric morbidity, platelet monoamine oxidase and tribulin output in headache.
    Littlewood J; Prasad A; Gibb C; Glover V; Sandler M; Joseph R; Rose FC
    Psychiatry Res; 1989 Oct; 30(1):95-102. PubMed ID: 2594876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine: the platelet hypothesis after 10 years.
    Hanington E
    Biomed Pharmacother; 1989; 43(10):719-26. PubMed ID: 2701286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine oxidase activities in patients with migraine or with cluster headache during the acute phases and after treatment with L-5-hydroxytryptophan.
    Bussone G; Boiardi A; Cerrati A; Girotti F; Merati B; Rivolta G
    Riv Patol Nerv Ment; 1979; 100(5):269-74. PubMed ID: 318025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood platelet 5-hydroxytryptamine accumulation and migraine.
    Carroll JD; Coppen A; Swade CC; Wood KM
    Ups J Med Sci Suppl; 1980; 31():10-2. PubMed ID: 6935852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of intensity and special characteristics of migraine to depressive and anxious features.
    Anagnostou E; Constantinides V; Anagnostou E; Paraskevas G; Christidi F; Zalonis I; Stamboulis E; Kararizou E
    Psychiatriki; 2013; 24(3):197-201. PubMed ID: 24185086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet monoamine oxidase in migraine.
    Thomas DV
    Adv Neurol; 1982; 33():279-81. PubMed ID: 7055008
    [No Abstract]   [Full Text] [Related]  

  • 29. Low platelet monoamine oxidase activity in headache: no correlation with phenolsulphotransferase, succinate dehydrogenase, platelet preparation method or smoking.
    Littlewood J; Glover V; Sandler M; Peatfield R; Petty R; Clifford Rose F
    J Neurol Neurosurg Psychiatry; 1984 Apr; 47(4):338-43. PubMed ID: 6587008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressor sensitivity to tyramine in patients with headache: relationship to platelet monoamine oxidase and to dietary provocation.
    Peatfield R; Littlewood JT; Glover V; Sandler M; Rose FC
    J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):827-31. PubMed ID: 6619891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin and migraine.
    Humphrey PP; Feniuk W; Perren MJ; Beresford IJ; Skingle M; Whalley ET
    Ann N Y Acad Sci; 1990; 600():587-98; discussion 598-600. PubMed ID: 2252337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transitory platelet monoamine oxidase deficit in migraine: some reflections.
    Sandler M
    Headache; 1977 Sep; 17(4):153-8. PubMed ID: 893087
    [No Abstract]   [Full Text] [Related]  

  • 33. Shared mechanisms of epilepsy, migraine and affective disorders.
    Zarcone D; Corbetta S
    Neurol Sci; 2017 May; 38(Suppl 1):73-76. PubMed ID: 28527083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.
    Samson JA; Gudeman JE; Schatzberg AF; Kizuka PP; Orsulak PJ; Cole JO; Schildkraut JJ
    J Psychiatr Res; 1985; 19(4):547-55. PubMed ID: 4078757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAO activity, serotonin metabolism and aggregation of platelets from migraine patients. A preliminary study.
    Kovács K; Tóthfalusi L; Hermán F; Magyar K
    Pol J Pharmacol Pharm; 1988; 40(6):691-5. PubMed ID: 3152004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of platelet 5-hydroxytryptamine by plasma taken from patients during and between migraine attacks.
    Dvilansky A; Rishpon S; Nathan I; Zolotow Z; Korczyn AD
    Pain; 1976 Sep; 2(3):315-318. PubMed ID: 1026904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of the platelet monoamine oxidase deficit during migraine attacks.
    Sandler M
    Res Clin Stud Headache; 1978; 6():65-72. PubMed ID: 725258
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tension-type headache: 5-hydroxytryptamine and related substances].
    Shimomura T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1342-4. PubMed ID: 8752392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.